Correlation Between Pasithea Therapeutics and Surrozen
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Surrozen, you can compare the effects of market volatilities on Pasithea Therapeutics and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Surrozen.
Diversification Opportunities for Pasithea Therapeutics and Surrozen
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pasithea and Surrozen is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Surrozen go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Surrozen
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Surrozen. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 2.22 times less risky than Surrozen. The stock trades about -0.23 of its potential returns per unit of risk. The Surrozen is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 1,425 in Surrozen on November 2, 2024 and sell it today you would lose (218.00) from holding Surrozen or give up 15.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. Surrozen
Performance |
Timeline |
Pasithea Therapeutics |
Surrozen |
Pasithea Therapeutics and Surrozen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and Surrozen
The main advantage of trading using opposite Pasithea Therapeutics and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |